Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trialFlorence Ader, Raphaël Clère-Jehl, Richard Greil et al.|The Lancet Infectious Diseases|2021Cited by 344
Review of European and American guidelines for the diagnosis of Lyme borreliosisCarole Eldin, Philippe Parola, A. Raffetin et al.|Médecine et Maladies Infectieuses|2018Cited by 119
Lyme borreliosis and other tick-borne diseases. Guidelines from the French Scientific Societies (I): prevention, epidemiology, diagnosisJulie Figoni, Pierre Tattevin, Catherine Chirouze et al.|Médecine et Maladies Infectieuses|2019Cited by 91
Lyme borreliosis and other tick-borne diseases. Guidelines from the French scientific societies (II). Biological diagnosis, treatment, persistent symptoms after documented or suspected Lyme borreliosisB. Jaulhac, Pierre Tattevin, A. Saunier et al.|Médecine et Maladies Infectieuses|2019Cited by 87
Utility of CT scan in patients with initial negative PCR for SARS-CoV2: a report of three casesKévin Bouiller, Catherine Chirouze|Infection|2020Cited by 3